223 related articles for article (PubMed ID: 29724201)
41. Chalcone Methoxy Derivatives Exhibit Antiproliferative and Proapoptotic Activity on Canine Lymphoma and Leukemia Cells.
Pawlak A; Henklewska M; Hernández Suárez B; Łużny M; Kozłowska E; Obmińska-Mrukowicz B; Janeczko T
Molecules; 2020 Sep; 25(19):. PubMed ID: 32977440
[TBL] [Abstract][Full Text] [Related]
42. Synthesis and biological evaluation of gold(III) Schiff base complexes for the treatment of hepatocellular carcinoma through attenuating TrxR activity.
Bian M; Wang X; Sun Y; Liu W
Eur J Med Chem; 2020 May; 193():112234. PubMed ID: 32213395
[TBL] [Abstract][Full Text] [Related]
43. Expression of the thioredoxin system in an in vivo-like cancer cell environment upon auranofin treatment.
Bhatia M; Lovitt CJ; Raninga PV; Avery VM; Di Trapani G; Tonissen KF
Eur J Cell Biol; 2016 Oct; 95(10):378-388. PubMed ID: 27567536
[TBL] [Abstract][Full Text] [Related]
44. Auranofin repurposing for lung and pancreatic cancer: low CA12 expression as a marker of sensitivity in patient-derived organoids, with potentiated efficacy by AKT inhibition.
Deben C; Boullosa LF; Fortes FR; De La Hoz EC; Le Compte M; Seghers S; Peeters M; Vanlanduit S; Lin A; Dijkstra KK; Van Schil P; Hendriks JMH; Prenen H; Roeyen G; Lardon F; Smits E
J Exp Clin Cancer Res; 2024 Mar; 43(1):88. PubMed ID: 38515178
[TBL] [Abstract][Full Text] [Related]
45. Auranofin-mediated inhibition of PI3K/AKT/mTOR axis and anticancer activity in non-small cell lung cancer cells.
Li H; Hu J; Wu S; Wang L; Cao X; Zhang X; Dai B; Cao M; Shao R; Zhang R; Majidi M; Ji L; Heymach JV; Wang M; Pan S; Minna J; Mehran RJ; Swisher SG; Roth JA; Fang B
Oncotarget; 2016 Jan; 7(3):3548-58. PubMed ID: 26657290
[TBL] [Abstract][Full Text] [Related]
46. The role of p38 MAPK activation in auranofin-induced apoptosis of human promyelocytic leukaemia HL-60 cells.
Park SJ; Kim IS
Br J Pharmacol; 2005 Oct; 146(4):506-13. PubMed ID: 16086031
[TBL] [Abstract][Full Text] [Related]
47. Cancer cell death induced by phosphine gold(I) compounds targeting thioredoxin reductase.
Gandin V; Fernandes AP; Rigobello MP; Dani B; Sorrentino F; Tisato F; Björnstedt M; Bindoli A; Sturaro A; Rella R; Marzano C
Biochem Pharmacol; 2010 Jan; 79(2):90-101. PubMed ID: 19665452
[TBL] [Abstract][Full Text] [Related]
48. Menadione Potentiates Auranofin-Induced Glioblastoma Cell Death.
Szeliga M; Rola R
Int J Mol Sci; 2022 Dec; 23(24):. PubMed ID: 36555352
[TBL] [Abstract][Full Text] [Related]
49. Repurposing auranofin to treat TP53-mutated or PTEN-deleted refractory B-cell lymphoma.
Wang J; Wang J; Lopez E; Guo H; Zhang H; Liu Y; Chen Z; Huang S; Zhou S; Leeming A; Zhang RJ; Jung D; Shi H; Grundman H; Doakes D; Cui K; Jiang C; Ahmed M; Nomie K; Fang B; Wang M; Yao Y; Zhang L
Blood Cancer J; 2019 Nov; 9(12):95. PubMed ID: 31780660
[No Abstract] [Full Text] [Related]
50. In vitro effects of doxorubicin and tetrathiomolybdate on canine hemangiosarcoma cells.
Sloan CQ; Rodriguez CO
Am J Vet Res; 2018 Feb; 79(2):219-225. PubMed ID: 29359968
[TBL] [Abstract][Full Text] [Related]
51. Auranofin Inhibition of Thioredoxin Reductase Sensitizes Lung Neuroendocrine Tumor Cells (NETs) and Small Cell Lung Cancer (SCLC) Cells to Sorafenib as well as Inhibiting SCLC Xenograft Growth.
Johnson SS; Liu D; Ewald JT; Robles-Planells C; Christensen KA; Bayanbold K; Wels BR; Solst SR; O'Dorisio MS; Allen BG; Menda Y; Spitz DR; Fath MA
bioRxiv; 2024 Jan; ():. PubMed ID: 37215042
[TBL] [Abstract][Full Text] [Related]
52. Auranofin Induces Lethality Driven by Reactive Oxygen Species in High-Grade Serous Ovarian Cancer Cells.
Abdalbari FH; Martinez-Jaramillo E; Forgie BN; Tran E; Zorychta E; Goyeneche AA; Sabri S; Telleria CM
Cancers (Basel); 2023 Oct; 15(21):. PubMed ID: 37958311
[TBL] [Abstract][Full Text] [Related]
53. New uses for old drugs. Auranofin, a clinically established antiarthritic metallodrug, exhibits potent antimalarial effects in vitro: Mechanistic and pharmacological implications.
Sannella AR; Casini A; Gabbiani C; Messori L; Bilia AR; Vincieri FF; Majori G; Severini C
FEBS Lett; 2008 Mar; 582(6):844-7. PubMed ID: 18294965
[TBL] [Abstract][Full Text] [Related]
54. Auranofin Synergizes with the PARP Inhibitor Olaparib to Induce ROS-Mediated Cell Death in Mutant p53 Cancers.
Freire Boullosa L; Van Loenhout J; Flieswasser T; Hermans C; Merlin C; Lau HW; Marcq E; Verschuuren M; De Vos WH; Lardon F; Smits ELJ; Deben C
Antioxidants (Basel); 2023 Mar; 12(3):. PubMed ID: 36978917
[TBL] [Abstract][Full Text] [Related]
55. Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Hopper M; Yun JF; Zhou B; Le C; Kehoe K; Le R; Hill R; Jongeward G; Debnath A; Zhang L; Miyamoto Y; Eckmann L; Land KM; Wrischnik LA
Int J Antimicrob Agents; 2016 Dec; 48(6):690-694. PubMed ID: 27839893
[TBL] [Abstract][Full Text] [Related]
56. Antitumor activity of gold(III)-dithiocarbamato derivatives on prostate cancer cells and xenografts.
Cattaruzza L; Fregona D; Mongiat M; Ronconi L; Fassina A; Colombatti A; Aldinucci D
Int J Cancer; 2011 Jan; 128(1):206-15. PubMed ID: 20209498
[TBL] [Abstract][Full Text] [Related]
57. Auranofin Enhances Sulforaphane-Mediated Apoptosis in Hepatocellular Carcinoma Hep3B Cells through Inactivation of the PI3K/Akt Signaling Pathway.
Hwangbo H; Kim SY; Lee H; Park SH; Hong SH; Park C; Kim GY; Leem SH; Hyun JW; Cheong J; Choi YH
Biomol Ther (Seoul); 2020 Sep; 28(5):443-455. PubMed ID: 32856616
[TBL] [Abstract][Full Text] [Related]
58. Upgrade of an old drug: Auranofin in innovative cancer therapies to overcome drug resistance and to increase drug effectiveness.
Gamberi T; Chiappetta G; Fiaschi T; Modesti A; Sorbi F; Magherini F
Med Res Rev; 2022 May; 42(3):1111-1146. PubMed ID: 34850406
[TBL] [Abstract][Full Text] [Related]
59. Cinnamaldehydes inhibit thioredoxin reductase and induce Nrf2: potential candidates for cancer therapy and chemoprevention.
Chew EH; Nagle AA; Zhang Y; Scarmagnani S; Palaniappan P; Bradshaw TD; Holmgren A; Westwell AD
Free Radic Biol Med; 2010 Jan; 48(1):98-111. PubMed ID: 19837157
[TBL] [Abstract][Full Text] [Related]
60. Repurposing of auranofin: Thioredoxin reductase remains a primary target of the drug.
Zhang X; Selvaraju K; Saei AA; D'Arcy P; Zubarev RA; Arnér ES; Linder S
Biochimie; 2019 Jul; 162():46-54. PubMed ID: 30946948
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
